230 related articles for article (PubMed ID: 28378518)
1. Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy.
Kane MS; Alban J; Desquiret-Dumas V; Gueguen N; Ishak L; Ferre M; Amati-Bonneau P; Procaccio V; Bonneau D; Lenaers G; Reynier P; Chevrollier A
J Cell Mol Med; 2017 Oct; 21(10):2284-2297. PubMed ID: 28378518
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency.
Kushnareva Y; Seong Y; Andreyev AY; Kuwana T; Kiosses WB; Votruba M; Newmeyer DD
Cell Death Dis; 2016 Jul; 7(7):e2309. PubMed ID: 27468686
[TBL] [Abstract][Full Text] [Related]
3. OPA1 haploinsufficiency induces a BNIP3-dependent decrease in mitophagy in neurons: relevance to Dominant Optic Atrophy.
Moulis MF; Millet AM; Daloyau M; Miquel MC; Ronsin B; Wissinger B; Arnauné-Pelloquin L; Belenguer P
J Neurochem; 2017 Feb; 140(3):485-494. PubMed ID: 27861891
[TBL] [Abstract][Full Text] [Related]
4. OPA1 mutation affects autophagy and triggers senescence in autosomal dominant optic atrophy plus fibroblasts.
Zanfardino P; Amati A; Doccini S; Cox SN; Tullo A; Longo G; D'Erchia A; Picardi E; Nesti C; Santorelli FM; Petruzzella V
Hum Mol Genet; 2024 Apr; 33(9):768-786. PubMed ID: 38280232
[TBL] [Abstract][Full Text] [Related]
5. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.
Yu-Wai-Man P; Shankar SP; Biousse V; Miller NR; Bean LJ; Coffee B; Hegde M; Newman NJ
Ophthalmology; 2011 Mar; 118(3):558-63. PubMed ID: 21036400
[TBL] [Abstract][Full Text] [Related]
6. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.
Zanna C; Ghelli A; Porcelli AM; Karbowski M; Youle RJ; Schimpf S; Wissinger B; Pinti M; Cossarizza A; Vidoni S; Valentino ML; Rugolo M; Carelli V
Brain; 2008 Feb; 131(Pt 2):352-67. PubMed ID: 18222991
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.
Liao C; Ashley N; Diot A; Morten K; Phadwal K; Williams A; Fearnley I; Rosser L; Lowndes J; Fratter C; Ferguson DJ; Vay L; Quaghebeur G; Moroni I; Bianchi S; Lamperti C; Downes SM; Sitarz KS; Flannery PJ; Carver J; Dombi E; East D; Laura M; Reilly MM; Mortiboys H; Prevo R; Campanella M; Daniels MJ; Zeviani M; Yu-Wai-Man P; Simon AK; Votruba M; Poulton J
Neurology; 2017 Jan; 88(2):131-142. PubMed ID: 27974645
[TBL] [Abstract][Full Text] [Related]
8. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.
Lodi R; Tonon C; Valentino ML; Manners D; Testa C; Malucelli E; La Morgia C; Barboni P; Carbonelli M; Schimpf S; Wissinger B; Zeviani M; Baruzzi A; Liguori R; Barbiroli B; Carelli V
Arch Neurol; 2011 Jan; 68(1):67-73. PubMed ID: 20837821
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
[TBL] [Abstract][Full Text] [Related]
10. First cases of dominant optic atrophy in Saudi Arabia: report of two novel OPA1 mutations.
Galvez-Ruiz A; Neuhaus C; Bergmann C; Bolz H
J Neuroophthalmol; 2013 Dec; 33(4):349-53. PubMed ID: 24051421
[TBL] [Abstract][Full Text] [Related]
11. Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations.
Nasca A; Rizza T; Doimo M; Legati A; Ciolfi A; Diodato D; Calderan C; Carrara G; Lamantea E; Aiello C; Di Nottia M; Niceta M; Lamperti C; Ardissone A; Bianchi-Marzoli S; Iarossi G; Bertini E; Moroni I; Tartaglia M; Salviati L; Carrozzo R; Ghezzi D
Orphanet J Rare Dis; 2017 May; 12(1):89. PubMed ID: 28494813
[TBL] [Abstract][Full Text] [Related]
12. Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models.
Del Dotto V; Fogazza M; Musiani F; Maresca A; Aleo SJ; Caporali L; La Morgia C; Nolli C; Lodi T; Goffrini P; Chan D; Carelli V; Rugolo M; Baruffini E; Zanna C
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3496-3514. PubMed ID: 30293569
[TBL] [Abstract][Full Text] [Related]
13. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
[TBL] [Abstract][Full Text] [Related]
14. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
[TBL] [Abstract][Full Text] [Related]
15. OPA1: How much do we know to approach therapy?
Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C
Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676
[TBL] [Abstract][Full Text] [Related]
16. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
[TBL] [Abstract][Full Text] [Related]
17. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.
Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q
Mol Vis; 2013; 19():292-302. PubMed ID: 23401657
[TBL] [Abstract][Full Text] [Related]
18. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.
Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M
Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.
Ham M; Han J; Osann K; Smith M; Kimonis V
Mitochondrion; 2019 May; 46():262-269. PubMed ID: 30165240
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]